1-3 of 3
A. Dagis
Close
Sort by
Journal Articles

Outcomes for Unrelated Donor Hematopoietic Cell Transplantation (URD-HCT) for Patients with Acute Lymphoblastic Leukemia (ALL) Using Fractionated Total Body Irradiation (FTBI) and Etoposide (VP16).

Margaret O’Donnell, P Parker, A Dagis, ML Slovak, D Snyder, A Stein, R. Spielberger, A Pawlowska, J Rosenthal, J Palmer, N. Kogut, S. J Forman
Journal: Blood
Blood (2008) 112 (11): 3286.
https://doi.org/10.1182/blood.V112.11.3286.3286
Published: 2008
Journal Articles

Incompatible Inhibitory KIR Ligands Contribute To Lower Survival Rates in Leukemia Patients Receiving T-Replete Hematopoietic Cell Transplants (HCTs).

J.Y. Sun, MD, A. Dagis, PhD, M.M. Miller, PhD, J. Longmate, PhD, R. Rodriguez, MD, L. Gaidulis, MS, S.J. Forman, MD, D. David, PhD
Journal: Blood
Blood (2005) 106 (11): 2054.
https://doi.org/10.1182/blood.V106.11.2054.2054
Published: 2005
Journal Articles

Analysis of Long Term Outcome in Autologous Stem Cell Transplant (ASCT) for Acute Myelogenous Leukemia (AML) in First Remission (CR1) - a 15 Year Experience.

Anthony Selwyn Stein, MD, M. O’Donnell, MD, P. Parker, MD, R. Spielberger, MD, A. Nademanee, MD, R. Bhatia, MD, D. S. Snyder, MD, M. Kirschbaum, MD, V. Pullarkat, MD, N. Kogut, MD, E. Bolotin, MD, K. Chang, MD, C. Sarkodee-Adoo, MD, M. Slovak, MD, N. Vora, MD, J. Land, RN, A. Dagis, J. Palmer, S. J. Forman, MD
Journal: Blood
Blood (2004) 104 (11): 1870.
https://doi.org/10.1182/blood.V104.11.1870.1870
Published: 2004